MOBIX LABS, INC (MOBX) Form 424B3 — Nov 16, 2026
Mobix Labs filed Prospectus Supplement No. 8 registering up to 2,412,711 Class A shares, incorporating an 8-K dated November 13, 2026 with three major disclosures. The board approved a 1-for-7 reverse stock split effective November 16, 2026, cutting shares outstanding from roughly 23.6 million to 3.4 million, explicitly to maintain Nasdaq minimum bid-price compliance with the stock at $0.51. Separately, Mobix and Special Project Delivery mutually terminated their August 2025 merger agreement after failing to obtain a fairness opinion, with no termination fees.
Key figures
- Revenue
- 1810000
- Accounts payable
- 4880000
- Total liabilities
- 29630000
- Reverse split ratio
- 1-for-7
- Stockholders equity
- 4870000
- Fiscal2026 stock comp
- 12300000
- Merger agreement date
- 2026-08-13
- Prior quarter revenue
- 789000
- Gross margin q4 prelim
- 44.5%
- Gross profit q4 prelim
- 804000
- Closing price nov13 2026
- 0.51
- Operating loss q4 prelim
- 6560000
- Product revenue q4 prelim
- 1430000
- Fiscal2026 net loss prelim
- 41860000
- Gross margin prior quarter
- 12.9%
- Shares outstanding pre split
- 23646570
- Shares outstanding post split
- 3378082
- Product revenue growth sequential
- 171%
- Registered shares under Prospectus
- 2412711
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.